trending Market Intelligence /marketintelligence/en/news-insights/trending/hxyvcislw80yjywaib3hgq2 content esgSubNav
In This List

Huakang Biomedical ups share offering to raise HK$16.6M after positive response

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Huakang Biomedical ups share offering to raise HK$16.6M after positive response

Huakang Biomedical Holdings Co. Ltd. plans to increase the size of its public offering of shares from 10 million to 100 million after the initial offering was oversubscribed.

The Hong Kong-based healthcare company has fixed the offering price at 50 Hong Kong cents per share and expects to raise HK$16.6 million in net proceeds.

Huakang Biomedical will use the proceeds to develop new products, improve existing ones and to fund its working capital. The company plans to start a supplementary reproductive business while expanding its sales network and marketing activities with the funds available.

RHB Capital Hong Kong Ltd. is the sole sponsor for the offering while Lead Securities Hong Kong Ltd. and Ever-Long Securities Co. Ltd. acted as joint book runners.

Huakang Biomedical develops medical devices used for diagnostic and monitoring purposes for sale in China.